Authors: Neill, GW Crompton, MR

Citation: Gw. Neill et Mr. Crompton, Binding of the merlin-I product of the neurofibromatosis type 2 tumour suppressor gene to a novel site in beta-fodrin is regulated by association between merlin domains, BIOCHEM J, 358, 2001, pp. 727-735

Authors: Kamalati, T Jolin, HE Fry, MJ Crompton, MR

Citation: T. Kamalati et al., Expression of the BRK tyrosine kinase in mammary epithelial cells enhancesthe coupling of EGF signalling to PI 3-kinase and Akt, via erbB3 phosphorylation, ONCOGENE, 19(48), 2000, pp. 5471-5476

Authors: Mitchell, PJ Sara, EA Crompton, MR

Citation: Pj. Mitchell et al., A novel adaptor-like protein which is a substrate for the non-receptor tyrosine kinase, BRK, ONCOGENE, 19(37), 2000, pp. 4273-4282

Authors: Smith, PD Crossland, S Parker, G Osin, P Brooks, L Waller, J Philp, E Crompton, MR Gusterson, BA Allday, MJ Crook, T

Citation: Pd. Smith et al., Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions, ONCOGENE, 18(15), 1999, pp. 2451-2459

Authors: Burke, F Smith, PD Crompton, MR Upton, C Balkwill, FR

Citation: F. Burke et al., Cytotoxic response of ovarian cancer cell lines to IFN-gamma is associatedwith sustained induction of IRF-1 and p21 mRNA, BR J CANC, 80(8), 1999, pp. 1236-1244

Authors: Kamalati, T Davies, D Titley, J Crompton, MR

Citation: T. Kamalati et al., Functional consequences of cyclin D1 overexpression in human mammary luminal epithelial cells, CLIN EXP M, 16(5), 1998, pp. 415-426